3Hui CK,Lau GKK.Current issure and future directions in treatment.Semin Liver Dis,2006,26:192-197.
4Lau GKK,Liang R,Lee CK,et al.Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant (BMT) recipients from anti-HBct/anti-HBstBMT donors.J Infect Dis,1998,178:1585-1591.
5Lau GKK,Lok ASF,Liang RHS,et al.Clearance of HBsAg after bone marrow transplantation:role of adoptive immunity transfer.Hepatology,1997,25:1497-1501.
6Hui CK,Zhang HY,Lee NP,et al.Upregulation of toll-like receptor 7 is essential for serological clearance of hepatitis B surface antigen in chronic hepatitis B virus infection.Hepatology,2005,42 (suppl 1):707A.
7Perrillo RP.Current treatment of chronic hepatitis B:benefits and limitations.Semin Liver Dis,2005,25 (Suppl 1):20 -28.
8Locarnini S.Molecular virology and the development of resistant mutants:Implications for therapy.Semin in Liver Dis,2005,25 (Suppl 1):9-19.
9Bartholomeusz A and Locarnini SA.Antiviral Drug Resistance:Clinical Consequences and Molecular Aspects.Semin Liver Dis,2006,26:162-170.
10Richman DD.The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B.Hepatology,2000,32:866-867.
